Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-800
Closed -$215K 198
2023
Q3
$215K Buy
+800
New +$200K 0.03% 163
2023
Q1
Sell
-800
Closed -$210K 164
2022
Q4
$210K Buy
+800
New +$214K 0.03% 164
2021
Q3
Sell
-800
Closed -$195K 160
2021
Q2
$195K Buy
+800
New +$197K 0.03% 148
2020
Q4
Sell
-800
Closed -$203K 144
2020
Q3
$203K Buy
+800
New +$198K 0.05% 137
2019
Q2
Sell
-19,871
Closed -$936K 142
2019
Q1
$936K Buy
+19,871
New +$3.79M 0.23% 91
2018
Q4
Sell
-800
Closed -$166K 141
2018
Q3
$166K Hold
800
0.04% 129
2018
Q2
$148K Hold
800
0.04% 134
2018
Q1
$136K Sell
800
-79
-9% -$14.5K 0.04% 140
2017
Q4
$153K Hold
879
0.04% 138
2017
Q3
$164K Buy
879
+32
+4% +$5.67K 0.05% 134
2017
Q2
$146K Hold
847
0.04% 141
2017
Q1
$139K Hold
847
0.04% 145
2016
Q4
$124K Buy
847
+47
+6% +$7.07K 0.04% 151
2016
Q3
$131K Hold
800
0.04% 138
2016
Q2
$122K Hold
800
0.04% 136
2016
Q1
$120K Hold
800
0.04% 138
2015
Q4
$130K Hold
800
0.05% 139
2015
Q3
$111K Hold
800
0.04% 147
2015
Q2
$123K Hold
800
0.04% 147
2015
Q1
$128K Sell
800
-2
-0.2% -$315 0.04% 140
2014
Q4
$128K Buy
+802
New +$125K 0.04% 143

Other funds holding AMGN

Isthmus Partners's AMGN Position: Q4 2023 in Review

Isthmus Partners sold out of Amgen (AMGN) in Q4 2023, closing a stake of 800 shares — an estimated $215K sold.

Isthmus Partners first reported a position in AMGN in Q4 2014 and held it in 21 quarters. The position peaked at $936K in Q1 2019. 2,714 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.

  • Isthmus Partners reported no remaining Amgen position as of Q4 2023 after selling out during the quarter.
  • Isthmus Partners sold 800 Amgen shares in Q4 2023, an estimated $215K.
  • Isthmus Partners first reported a position in Amgen in Q4 2014 and held it in 21 quarters.
  • Isthmus Partners's Amgen position peaked at $936K in Q1 2019.
  • 2,714 funds tracked by Wall St. Rank held Amgen as of Q4 2023.

Based on Isthmus Partners's 13F filing for Q4 2023, filed 12 Feb 2024.